Survival Outcomes of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Treated in US Community Oncology

Cancer Patients ◽

Survival Outcomes ◽

Community Oncology ◽

Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials

Annals of Oncology ◽

10.1016/j.annonc.2019.10.005 ◽

2020 ◽

Vol 31 (1) ◽

pp. 88-95 ◽

Cited By ~ 5

Author(s):

T. Yoshino ◽

J.M. Cleary ◽

E. Van Cutsem ◽

R.J. Mayer ◽

A. Ohtsu ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Survival Outcomes ◽

P-78 Early tumour shrinkage, depth of response and survival outcomes for RAS wild-type metastatic colorectal cancer patients classified by baseline tumour load: Retrospective pooled analysis of panitumumab PRIME/PEAK studies

Annals of Oncology ◽

10.1016/j.annonc.2020.04.160 ◽

2020 ◽

Vol 31 ◽

pp. S114-S115

Author(s):

F. Loupakis ◽

M. Peeters ◽

M. Geissler ◽

D. Modest ◽

M. Valladares-Ayerbes ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Pooled Analysis ◽

Survival Outcomes ◽

Wild Type ◽

Depth Of Response ◽

Tumour Load ◽

Tumour Shrinkage ◽

511P Real-world survival outcomes of Asian metastatic colorectal cancer patients undergoing hepatectomy from the AsianmCRCRegistry

Annals of Oncology ◽

10.1016/j.annonc.2020.08.621 ◽

2020 ◽

Vol 31 ◽

pp. S456

Author(s):

C. Teh ◽

S. Cai ◽

J-K. Lin ◽

Y.S. Park ◽

T.W. Kim ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Real World ◽

Survival Outcomes ◽

Association of Neutrophil-to-Lymphocyte Ratio With Survival Outcomes in Metastatic Colorectal Cancer Patients Treated With Selective Internal Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.1051 ◽

2017 ◽

Vol 99 (2) ◽

pp. E188

Author(s):

J.C. Shiao ◽

H. Winter ◽

T. Greenhalgh ◽

P. Virdee ◽

M. Little ◽

...

Keyword(s):

Colorectal Cancer ◽

Radiation Therapy ◽

Cancer Patients ◽

Neutrophil To Lymphocyte Ratio ◽

Survival Outcomes ◽

Selective Internal Radiation Therapy ◽

Internal Radiation ◽

Lymphocyte Ratio ◽

Panitumumab Provides Better Survival Outcomes Compared to Cetuximab for Metastatic Colorectal Cancer Patients Treated with Prior Bevacizumab within 6 Months

Oncology ◽

10.1159/000493321 ◽

2018 ◽

Vol 96 (3) ◽

pp. 132-139 ◽

Cited By ~ 1

Author(s):

Kaori Hayashi ◽

Seiichiro Mitani ◽

Hiroya Taniguchi ◽

Hirofumi Yasui ◽

Kei Muro ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Survival Outcomes ◽

Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy

World Journal of Gastrointestinal Oncology ◽

10.4251/wjgo.v10.i11.431 ◽

2018 ◽

Vol 10 (11) ◽

pp. 431-438 ◽

Cited By ~ 1

Author(s):

Hang-Yu Zhang ◽

Jian-Hai Guo ◽

Song Gao ◽

Hui Chen ◽

Xiao-Dong Wang ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Primary Tumor ◽

Hepatic Arterial Infusion ◽

Survival Outcomes ◽

Arterial Infusion ◽

Arterial Infusion Chemotherapy ◽

Infusion Chemotherapy ◽

Faculty Opinions recommendation of Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726943980.793538773 ◽

2017 ◽

Author(s):

Noelle LoConte ◽

Kieran Sahasrabudhe

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Iii ◽

First Line ◽

Phase Iii Study ◽

Colorectal Cancer Patients ◽

Line Chemotherapy

A phase I and pharmacokinetic study of irinotecan given as a 7 days continuous infusion in metastatic colorectal cancer patients pretreated with 5-FU or raltitrexed

European Journal of Cancer ◽

10.1016/s0959-8049(01)81579-3 ◽

2001 ◽

Vol 37 ◽

pp. S294-S295

Author(s):

G. Masi ◽

A. Di Paolo ◽

G. Allegrini ◽

S. Cupini ◽

C. Galli ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Continuous Infusion ◽

Cancer Patients ◽

Pharmacokinetic Study ◽

47P Loss-of-function PTPRT and PTPRD mutations predict bevacizumab resistance in metastatic colorectal cancer patients

Annals of Oncology ◽

10.1016/s0923-7534(21)00207-6 ◽

2016 ◽

Vol 27 ◽

pp. ix14

Author(s):

K.T. Tan ◽

S.-J. Chen ◽

H.-C. Chen ◽

H. Hung-Chih

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Loss Of Function ◽

Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection: effect of ACE-2 expression on tumor cells or molecular mimicry phenomena? Two not mutually exclusive hypotheses

Therapeutic Advances in Medical Oncology ◽

10.1177/17588359211027825 ◽

2021 ◽

Vol 13 ◽

pp. 175883592110278

Author(s):

Francesco Cappello ◽

Stefano Burgio ◽

Everly Conway de Macario ◽

Alberto J. L. Macario

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Molecular Mimicry ◽

Tumor Reduction ◽